Post-hepatectomy liver regeneration in the context of bile acid homeostasis and the gut-liver signaling axis
Background: Liver regeneration following partial hepatectomy (PHx) is a complicated process involving multiple organs and several types of signaling networks. The bile acid-activated metabolic pathways occupy an auxiliary yet important chapter in the entire biochemical phenomenon. PHx is characterized by rapid but transient bile acid overload in the liver, which constitutes the first wave of proliferative signaling in the remnant hepatocytes. Bile acids trigger hepatocyte proliferation through activation of several nuclear receptors. The enterocytes reabsorb the bile acids, which results in the activation of farnesoid X receptor (FXR), the consequent excretion of fibroblast growth factor (FGF)19/FGF15, and its release into the enterohepatic circulation. FGF19/FGF15 subsequently binds to its cognate receptor, fibroblast growth factor receptor 4 (FGFR4) complexed with β-klotho, on hepatocytes, which initiates the second wave of proliferative signaling. Because bile acids are potentially toxic, the remnant hepatocytes must resolve the potentially detrimental state of bile acid excess. Therefore, the hepatocytes orchestrate a bile acid detoxification and elimination response as a protective mechanism in concurrence with the proliferative signaling. The response results in the excretion of (biotransformed) bile acids into the canalicular system, causing the bile acids to end up in the intestine.
Relevance for patients: Recently, FXR agonists have been shown to promote regeneration via the gut-liver axis. This type of pharmacological intervention may prove beneficial for patients with hepatobiliary malignancies undergoing PHx. In light of these developments, this review provides an in-depth account of the pathways that underlie post-PHx liver regeneration in the context of bile acid homeostasis in the liver and the gut-liver signaling axis.
[1] Hoekstra LT, de Graaf W, Nibourg GA, Heger M, Bennink RJ, Stieger B, van Gulik TM. Physiological and biochemical basis of clinical liver function tests: A review. Ann Surg 2013;257:27-36.
[2] Michalopoulos GK. Advances in liver regeneration. Exp Rev Gastroenterol Hepatol 2014;8:897-907.
[3] Bismuth H, Majno PE. Hepatobiliary surgery. J Hepatol 2000;32:208-224.
[4] Togo S, Makino H, Kobayashi T, Morita T, Shimizu T, Kubota T, Ichikawa Y, Ishikawa T, Okazaki Y, Hayashizaki Y, Shimada H. Mechanism of liver regeneration after partial hepatectomy using mouse cdna microarray. J Hepatol 2004;40:464-471.
[5] Liao Y, Shikapwashya ON, Shteyer E, Dieckgraefe BK, Hruz PW, Rudnick DA. Delayed hepatocellular mitotic progression and impaired liver regeneration in early growth response-1- deficient mice. J Biol Chem 2004;279:43107-43116.
[6] Talarmin H, Rescan C, Cariou S, Glaise D, Zanninelli G, Bilodeau M, Loyer P, Guguen-Guillouzo C, Baffet G. The mitogen-activated protein kinase kinase/extracellular signal- regulated kinase cascade activation is a key signalling pathway involved in the regulation of g(1) phase progression in proliferating hepatocytes. Mol Cell Biol 1999;19:6003-6011.
[7] Markiewski MM, DeAngelis RA, Strey CW, Foukas PG, Gerard C, Gerard N, Wetsel RA, Lambris JD. The regulation of liver cell survival by complement. J Immunol 2009;182:5412- 5418.
[8] Strey CW, Markiewski M, Mastellos D, Tudoran R, Spruce LA, Greenbaum LE, Lambris JD. The proinflammatory mediators c3a and c5a are essential for liver regeneration. J Exp Med 2003;198:913-923.
[9] Strey CW, Siegmund B, Rosenblum S, Marquez-Pinilla RM, Oppermann E, Huber-Lang M, Lambris JD, Bechstein WO. Complement and neutrophil function changes after liver resection in humans. World J Surg 2009;33:2635-2643.
[10] Strey CW, Siegmund B, Rosenblum S, Marquez-Pinilla RM, Oppermann E, Huber-Lang M, Lambris JD, Bechstein WO. Complement and neutrophil function changes after liver resection in humans. World J Surg 2009;33:2635-2643.
[11] van de Poll MC, Derikx JP, Buurman WA, Peters WH, Roelofs HM, Wigmore SJ, Dejong CH. Liver manipulation causes hepatocyte injury and precedes systemic inflammation in patients undergoing liver resection. World J Surg 2007;31:2033-2038.
[12] van den Broek MA, Shiri-Sverdlov R, Schreurs JJ, Bloemen JG, Bieghs V, Rensen SS, Dejong CH, Olde Damink SW. Liver manipulation during liver surgery in humans is associated with hepatocellular damage and hepatic inflammation. Liver Int 2013;33:633-641.
[13] van Golen RF, van Gulik TM, Heger M. The sterile immune response during hepatic ischemia/reperfusion. Cytokine Growth Factor Rev 2012;23:69-84.
[14] Chen GY, Nunez G. Sterile inflammation: Sensing and reacting to damage. Nat Rev Immunol 2010;10:826-837.
[15] Oe S, Lemmer ER, Conner EA, Factor VM, Leveen P, Larsson J, Karlsson S, Thorgeirsson SS. Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice. Hepatology 2004;40:1098-1105.
[16] Romero-Gallo J, Sozmen EG, Chytil A, Russell WE, Whitehead R, Parks WT, Holdren MS, Her MF, Gautam S, Magnuson M, Moses HL, Grady WM. Inactivation of tgf-beta signaling in hepatocytes results in an increased proliferative response after partial hepatectomy. Oncogene 2005;24:3028- 3041.
[17] Hammond JS, Guha IN, Beckingham IJ, Lobo DN. Prediction, prevention and management of postresection liver failure. Br J Surg 2011;98:1188-1200.
[18] Dahm F, Georgiev P, Clavien PA. Small-for-size syndrome after partial liver transplantation: Definition, mechanisms of disease and clinical implications. Am J Transplant 2005;5:2605-2610.
[19] Columbano A, Ledda-Columbano GM. Mitogenesis by ligands of nuclear receptors: An attractive model for the study of the molecular mechanisms implicated in liver growth. Cell Death Differ 2003;10 Suppl 1:S19-21.
[20] Vacca M, Degirolamo C, Massafra V, Polimeno L, Mariani- Costantini R, Palasciano G, Moschetta A. Nuclear receptors in regenerating liver and hepatocellular carcinoma. Mol Cell Endocrinol 2013;368:108-119.
[21] Naugler WE. Bile acid flux is necessary for normal liver regeneration. PLoS One 2014;9:e97426.
[22] Uriarte I, Fernandez-Barrena MG, Monte MJ, Latasa MU, Chang HC, Carotti S, Vespasiani-Gentilucci U, Morini S, Vicente E, Concepcion AR, Medina JF, Marin JJ, Berasain C, Prieto J, Avila MA. Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice. Gut 2013;62:899-910.
[23] Padrissa-Altes S, Bachofner M, Bogorad RL, Pohlmeier L, Rossolini T, Bohm F, Liebisch G, Hellerbrand C, Koteliansky V, Speicher T, Werner S. Control of hepatocyte proliferation and survival by fgf receptors is essential for liver regeneration in mice. Gut 2015;64:1444-1453.
[24] Monte MJ, Martinez-Diez MC, El-Mir MY, Mendoza ME, Bravo P, Bachs O, Marin JJ. Changes in the pool of bile acids in hepatocyte nuclei during rat liver regeneration. J Hepatol 2002;36:534-542.
[25] Doignon I, Julien B, Serriere-Lanneau V, Garcin I, Alonso G, Nicou A, Monnet F, Gigou M, Humbert L, Rainteau D, Azoulay D, Castaing D, Gillon MC, Samuel D, Duclos-Vallee JC, Tordjmann T. Immediate neuroendocrine signaling after partial hepatectomy through acute portal hyperpressure and cholestasis. J Hepatol 2011;54:481-488.
[26] Pean N, Doignon I, Garcin I, Besnard A, Julien B, Liu B, Branchereau S, Spraul A, Guettier C, Humbert L, Schoonjans K, Rainteau D, Tordjmann T. The receptor tgr5 protects the liver from bile acid overload during liver regeneration in mice. Hepatology 2013;58:1451-1460.
[27] Xie Y, Wang H, Cheng X, Wu Y, Cao L, Wu M, Xie W, Wang G, Hao H. Farnesoid x receptor activation promotes cell proliferation via pdk4-controlled metabolic reprogramming. Sci Rep 2016;6:18751.
[28] Huang W, MaK, Zhang J, Qatanani M, Cuvillier J, Liu J, Dong B, Huang X, Moore DD. Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science 2006;312:233-236.
[29] Naugler WE, Tarlow BD, Fedorov LM, Taylor M, Pelz C, Li B, Darnell J, Grompe M. Fibroblast growth factor signaling controls liver size in mice with humanized livers. Gastroenterology 2015;149:728-740.
[30] Jansen PL, Schaap FG. Pandora's box opens for cholestatic liver disease. Hepatology 2016;63:694-696.
[31] Schaap FG, Trauner M, Jansen PL. Bile acid receptors as targets for drug development. Nat Rev Gastroenterol Hepatol 2014;11:55-67.
[32] Olthof PB, Huisman F, Schaap FG, van Lienden KP, Bennink RJ, van Golen RF, Heger M, Verheij J, Jansen PL, Olde Damink SW, van Gulik TM. Effect of obeticholic acid on liver regeneration following portal vein embolization in an experimental model. Br J Surg 2017;104:590-599.
[33] Beuers U, Trauner M, Jansen P, Poupon R. New paradigms in the treatment of hepatic cholestasis: From udca to fxr, pxr and beyond. J Hepatol 2015;62:S25-37.
[34] Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997;276:60-66.
[35] Grisham JW. A morphologic study of deoxyribonucleic acid synthesis and cell proliferation in regenerating rat liver; autoradiography with thymidine-h3. Cancer Res 1962;22:842- 849.
[36] Taub R. Liver regeneration: From myth to mechanism. Nat Rev Mol Cell Biol 2004;5:836-847.
[37] Mao SA, Glorioso JM, Nyberg SL. Liver regeneration. Transl Res 2014;163:352-362.
[38] Lock JF, Malinowski M, Seehofer D, Hoppe S, Rohl RI, Niehues SM, Neuhaus P, Stockmann M. Function and volume recovery after partial hepatectomy: Influence of preoperative liver function, residual liver volume, and obesity. Langenbecks Arch Surg 2012;397:1297-1304.
[39] Nagasue N, Yukaya H, Ogawa Y, Kohno H, Nakamura T. Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis. Ann Surg 1987;206:30-39.
[40] Riehle KJ, Dan YY, Campbell JS, Fausto N. New concepts in liver regeneration. J Gastroenterol Hepatol 2011;26:203-212.
[41] Satyanarayana A, Geffers R, Manns MP, Buer J, Rudolph KL. Gene expression profile at the g1/s transition of liver regeneration after partial hepatectomy in mice. Cell Cycle 2004;3:1405-1417.
[42] Meyer J, Lejmi E, Fontana P, Morel P, Gonelle-Gispert C, Buhler L. A focus on the role of platelets in liver regeneration: Do platelet-endothelial cell interactions initiate the regenerative process? J Hepatol 2015;63:1263-1271.
[43] Kang LI, Mars WM, Michalopoulos GK. Signals and cells involved in regulating liver regeneration. Cells 2012;1:1261- 1292.
[44] Michalopoulos GK. Liver regeneration after partial hepatectomy: Critical analysis of mechanistic dilemmas. Am J Pathol 2010;176:2-13.
[45] Marubashi S, Sakon M, Nagano H, Gotoh K, Hashimoto K, Kubota M, Kobayashi S, Yamamoto S, Miyamoto A, Dono K, Nakamori S, Umeshita K, Monden M. Effect of portal hemodynamics on liver regeneration studied in a novel portohepatic shunt rat model. Surgery 2004;136:1028-1037.
[46] Lee S, Broelsch CE, Flamant YM, Chandler JG, Charters AC, 3rd, Orloff MJ. Liver regeneration after portacaval transportation in rats. Surgery 1975;77:144-149.
[47] Starlinger P, Haegele S, Offensperger F, Oehlberger L, Pereyra D, Kral JB, Schrottmaier WC, Badrnya S, Reiberger T, Ferlitsch A, Stift J, LufF, Brostjan C, Gruenberger T, Assinger A. The profile of platelet alpha-granule released molecules affects postoperative liver regeneration. Hepatology 2016;63:1675-1688.
[48] Zhang JN, Bergeron AL, Yu Q, Sun C, McIntire LV, Lopez JA, Dong JF. Platelet aggregation and activation under complex patterns of shear stress. Thromb Haemost 2002;88:817-821.
[49] van Golen RF, Stevens KM, Colarusso P, Jaeschke H, Heger M. Platelet aggregation but not activation and degranulation during the acute post-ischemic reperfusion phase in livers with no underlying disease. J Clin Transl Res 2015;1:107-115.
[50] Wack KE, Ross MA, Zegarra V, Sysko LR, Watkins SC, Stolz DB. Sinusoidal ultrastructure evaluated during the revascularization of regenerating rat liver. Hepatology 2001;33:363-378.
[51] Nakamura M, Shibazaki M, Nitta Y, Endo Y. Translocation of platelets into disse spaces and their entry into hepatocytes in response to lipopolysaccharides, interleukin-1 and tumour necrosis factor: The role of kupffer cells. J Hepatol 1998;28:991-999.
[52] Endo Y, Nakamura M. The effect of lipopolysaccharide, interleukin-1 and tumour necrosis factor on the hepatic accumulation of 5-hydroxytryptamine and platelets in the mouse. Br J Pharmacol 1992;105:613-619.
[53] Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007;356:1545-1559.
[54] Wuestefeld T, Klein C, Streetz KL, Betz U, Lauber J, Buer J, Manns MP, Muller W, Trautwein C. Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration. J Biol Chem 2003;278:11281-11288.
[55] Iimuro Y, Fujimoto J. Tlrs, nf-kappab, jnk, and liver regeneration. Gastroenterol Res Pract 2010;598109.
[56] Michalopoulos GK. Principles of liver regeneration and growth homeostasis. Compr Physiol 2013;3:485-513.
[57] Marshall KM, He S, Zhong Z, Atkinson C, Tomlinson S. Dissecting the complement pathway in hepatic injury and regeneration with a novel protective strategy. J Exp Med 2014;211:1793-1805.
[58] DeAngelis RA, Markiewski MM, Kourtzelis I, Rafail S, Syriga M, Sandor A, Maurya MR, Gupta S, Subramaniam S, Lambris JD. A complement-il-4 regulatory circuit controls liver regeneration. J Immunol 2012;188:641-648.
[59] DeAngelis RA, Markiewski MM, Lambris JD. Liver regeneration: A link to inflammation through complement. Adv Exp Med Biol 2006;586:17-34.
[60] Liu HX, Keane R, Sheng L, Wan YJ. Implications of microbiota and bile acid in liver injury and regeneration. J Hepatol 2015;63:1502-1510.
[61] Liu HX, Rocha CS, Dandekar S, Wan YY. Functional analysis of the relationship between intestinal microbiota and the expression of hepatic genes and pathways during the course of liver regeneration. J Hepatol 2016;64:641-650.
[62] Sakaguchi T, Nakamura S, Suzuki S, Baba S, Nakashima M. Endogenous endotoxemia after massive hepatectomy and portal vein stenosis: Beneficial effect of a prostaglandin i2 analogue on intestinal permeability. Eur Surg Res 1996;28:341-350.
[63] Cornell RP. Gut-derived endotoxin elicits hepatotrophic factor secretion for liver regeneration. Am J Physiol 1985;249:R551- 562.
[64] Gao B, Jeong WI, Tian Z. Liver: An organ with predominant innate immunity. Hepatology 2008;47:729-736.
[65] Cornell RP, Liljequist BL, Bartizal KF. Depressed liver regeneration after partial hepatectomy of germ-free, athymic and lipopolysaccharide-resistant mice. Hepatology 1990;11:916-922.
[66] Cienfuegos JA, Rotellar F, Baixauli J, Martínez-Regueira F, Pardo F, Hernández-Lizoáin JL. Liver regeneration--the best kept secret. A model of tissue injury response. Rev Esp Enferm Dig 2014;106:171-194.
[67] van Golen RF, van Gulik TM, Heger M. Mechanistic overview of reactive species-induced degradation of the endothelial glycocalyx during hepatic ischemia/reperfusion injury. Free Radic Biol Med 2012;52:1382-1402.
[68] van Golen RF, Reiniers MJ, Vrisekoop N, Zuurbier CJ, Olthof PB, van Rheenen J, van Gulik TM, Parsons BJ, Heger M. The mechanisms and physiological relevance of glycocalyx degradation in hepatic ischemia/reperfusion injury. Antioxid Redox Signal 2014;21:1098-1118.
[69] Kloek JJ, Marechal X, Roelofsen J, Houtkooper RH, van Kuilenburg AB, Kulik W, Bezemer R, Neviere R, van Gulik TM, Heger M. Cholestasis is associated with hepatic microvascular dysfunction and aberrant energy metabolism before and during ischemia-reperfusion. Antioxid Redox Signal 2012;17:1109-1123.
[70] Reiniers MJ, van Golen RF, van Gulik TM, Heger M. Reactive oxygen and nitrogen species in steatotic hepatocytes: A molecular perspective on the pathophysiology of ischemia- reperfusion injury in the fatty liver. Antioxid Redox Signal 2014;21:1119-1142.
[71] Bai H, Zhang W, Qin XJ, Zhang T, Wu H, Liu JZ, Hai CX. Hydrogen peroxide modulates the proliferation/quiescence switch in the liver during embryonic development and posthepatectomy regeneration. Antioxid Redox Signal 2015;22:921-937.
[72] Dayoub R, Vogel A, Schuett J, Lupke M, Spieker SM, Kettern N, Hildt E, Melter M, Weiss TS. Nrf2 activates augmenter of liver regeneration (alr) via antioxidant response element and links oxidative stress to liver regeneration. Mol Med 2013;19:237-244.
[73] Hu M, Zou Y, Nambiar SM, Lee J, Yang Y, Dai G. Keap1 modulates the redox cycle and hepatocyte cell cycle in regenerating liver. Cell Cycle 2014;13:2349-2358.
[74] Kohler UA, Kurinna S, Schwitter D, Marti A, Schafer M, Hellerbrand C, Speicher T, Werner S. Activated nrf2 impairs liver regeneration in mice by activation of genes involved in cell-cycle control and apoptosis. Hepatology 2014;60:670-678.
[75] Wakabayashi N, Shin S, Slocum SL, Agoston ES, Wakabayashi J, Kwak MK, Misra V, Biswal S, Yamamoto M, Kensler TW. Regulation of notch1 signaling by nrf2: Implications for tissue regeneration. Sci Signal 2010;3:ra52.
[76] Kohler C, Bell AW, Bowen WC, Monga SP, Fleig W, Michalopoulos GK. Expression of notch-1 and its ligand jagged-1 in rat liver during liver regeneration. Hepatology 2004;39:1056-1065.
[77] Goodrich DW, Wang NP, Qian YW, Lee EY, Lee WH. The retinoblastoma gene product regulates progression through the g1 phase of the cell cycle. Cell 1991;67:293-302.
[78] Weintraub SJ, Prater CA, Dean DC. Retinoblastoma protein switches the e2f site from positive to negative element. Nature 1992;358:259-261.
[79] Nelsen CJ, Rickheim DG, Timchenko NA, Stanley MW, Albrecht JH. Transient expression of cyclin d1 is sufficient to promote hepatocyte replication and liver growth in vivo. Cancer Res 2001;61:8564-8568.
[80] Lavoie JN, Rivard N, L'Allemain G, Pouyssegur J. A temporal and biochemical link between growth factor-activated map kinases, cyclin d1 induction and cell cycle entry. Prog Cell Cycle Res 1996;2:49-58.
[81] Lavoie JN, L'Allemain G, Brunet A, Muller R, Pouyssegur J. Cyclin d1 expression is regulated positively by the p42/p44mapk and negatively by the p38/hogmapk pathway. J Biol Chem 1996;271:20608-20616.
[82] Beyer TA, Xu W, Teupser D, auf dem Keller U, Bugnon P, Hildt E, Thiery J, Kan YW, Werner S. Impaired liver regeneration in nrf2 knockout mice: Role of ros-mediated insulin/igf-1 resistance. EMBO J 2008;27:212-223.
[83] Yan LJ, Rajasekaran NS, Sathyanarayanan S, Benjamin IJ. Mouse hsf1 disruption perturbs redox state and increases mitochondrial oxidative stress in kidney. Antioxid Redox Signal 2005;7:465-471.
[84] Taub R. Liver regeneration 4: Transcriptional control of liver regeneration. FASEB J 1996;10:413-427.
[85] Aldeguer X, Debonera F, Shaked A, Krasinkas AM, Gelman AE, Que X, Zamir GA, Hiroyasu S, Kovalovich KK, Taub R, Olthoff KM. Interleukin-6 from intrahepatic cells of bone marrow origin is required for normal murine liver regeneration. Hepatology 2002;35:40-48.
[86] Akerman P, Cote P, Yang SQ, McClain C, Nelson S, Bagby GJ, Diehl AM. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am J Physiol 1992;263:G579-585.
[87] Kirillova I, Chaisson M, Fausto N. Tumor necrosis factor induces DNA replication in hepatic cells through nuclear factor kappab activation. Cell Growth Differ 1999;10:819-828.
[88] FitzGerald MJ, Webber EM, Donovan JR, Fausto N. Rapid DNA binding by nuclear factor kappa b in hepatocytes at the start of liver regeneration. Cell Growth Differ 1995;6:417-427.
[89] Yatomi Y, Ohmori T, Rile G, Kazama F, Okamoto H, Sano T, Satoh K, Kume S, Tigyi G, Igarashi Y, Ozaki Y. Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells. Blood 2000;96:3431-3438.
[90] Kawasaki T, Murata S, Takahashi K, Nozaki R, Ohshiro Y, Ikeda N, Pak S, Myronovych A, Hisakura K, Fukunaga K, Oda T, Sasaki R, Ohkohchi N. Activation of human liver sinusoidal endothelial cell by human platelets induces hepatocyte proliferation. J Hepatol 2010;53:648-654.
[91] Nowatari T, Murata S, Nakayama K, Sano N, Maruyama T, Nozaki R, Ikeda N, Fukunaga K, Ohkohchi N. Sphingosine 1- phosphate has anti-apoptotic effect on liver sinusoidal endothelial cells and proliferative effect on hepatocytes in a paracrine manner in human. Hepatol Res 2015;45:1136-1145.
[92] Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, Taub R. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274:1379-1383.
[93] Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type i tumor necrosis factor receptor. Proc Natl Acad Sci U S A 1997;94:1441-1446.
[94] Li W, Liang X, Leu JI, Kovalovich K, Ciliberto G, Taub R. Global changes in interleukin-6-dependent gene expression patterns in mouse livers after partial hepatectomy. Hepatology 2001;33:1377-1386.
[95] Haber BA, Mohn KL, Diamond RH, Taub R. Induction patterns of 70 genes during nine days after hepatectomy define the temporal course of liver regeneration. J Clin Invest 1993;91:1319-1326.
[96] Levy DE, Lee CK. What does stat3 do? J Clin Invest 2002;109:1143-1148.
[97] Columbano A, Shinozuka H. Liver regeneration versus direct hyperplasia. FASEB J 1996;10:1118-1128.
[98] Michalopoulos GK, Khan Z. Liver regeneration, growth factors, and amphiregulin. Gastroenterology 2005;128:503- 506.
[99] Wang L, Wang X, Wang L, Chiu JD, van de Ven G, Gaarde WA, Deleve LD. Hepatic vascular endothelial growth factor regulates recruitment of rat liver sinusoidal endothelial cell progenitor cells. Gastroenterology 2012;143:1555-1563.
[100] Shimizu H, Miyazaki M, Wakabayashi Y, Mitsuhashi N, Kato A, Ito H, Nakagawa K, Yoshidome H, Kataoka M, Nakajima N. Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats. J Hepatol 2001;34:683-689.
[101] Taniguchi E, Sakisaka S, Matsuo K, Tanikawa K, Sata M. Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. J Histochem Cytochem 2001;49:121-130.
[102] Mochida S, Ishikawa K, Inao M, Shibuya M, Fujiwara K. Increased expressions of vascular endothelial growth factor and its receptors, flt-1 and kdr/flk-1, in regenerating rat liver. Biochem Biophys Res Commun 1996;226:176-179.
[103] Matsuo R, Nakano Y, Ohkohchi N. Platelet administration via the portal vein promotes liver regeneration in rats after 70% hepatectomy. Ann Surg 2011;253:759-763.
[104] Murata S, Matsuo R, Ikeda O, Myronovych A, Watanabe M, Hisakura K, Nakano Y, Hashimoto I, Ohkohchi N. Platelets promote liver regeneration under conditions of kupffer cell depletion after hepatectomy in mice. World J Surg 2008;32:1088-1096.
[105] Rendu F, Brohard-Bohn B. The platelet release reaction: Granules' constituents, secretion and functions. Platelets 2001;12:261-273.
[106] Nurden AT, Nurden P, Sanchez M, Andia I, Anitua E. Platelets and wound healing. Front Biosci 2008;13:3532-3548.
[107] Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 1983;258:7155-7160.
[108] Lesurtel M, Graf R, Aleil B, Walther DJ, Tian Y, Jochum W, Gachet C, Bader M, Clavien PA. Platelet-derived serotonin mediates liver regeneration. Science 2006;312:104-107.
[109] Hong F, Nguyen VA, Shen X, Kunos G, Gao B. Rapid activation of protein kinaseb/akt has a key role in antiapoptotic signaling during liver regeneration. Biochem Biophys Res Commun 2000;279:974-979.
[110] Matsuo R, Ohkohchi N, Murata S, Ikeda O, Nakano Y, Watanabe M, Hisakura K, Myronovych A, Kubota T, Narimatsu H, Ozaki M. Platelets strongly induce hepatocyte proliferation with igf-1 and hgf in vitro. J Surg Res 2008;145:279-286.
[111] Nejak-Bowen K, Orr A, Bowen WC, Jr., Michalopoulos GK. Conditional genetic elimination of hepatocyte growth factor in mice compromises liver regeneration after partial hepatectomy. PLoS One 2013;8:e59836.
[112] Furrer K, Rickenbacher A, TianY, Jochum W, Bittermann AG, Kach A, Humar B, Graf R, Moritz W, Clavien PA. Serotonin reverts age-related capillarization and failure of regeneration in the liver through a vegf-dependent pathway. Proc Natl Acad Sci U S A 2011;108:2945-2950.
[113] LeCouter J, Moritz DR, Li B, Phillips GL, Liang XH, Gerber HP, Hillan KJ, Ferrara N. Angiogenesis-independent endothelial protection of liver: Role of vegfr-1. Science 2003;299:890-893.
[114] Ding BS, Nolan DJ, Butler JM, James D, Babazadeh AO, Rosenwaks Z, Mittal V, Kobayashi H, Shido K, Lyden D, Sato TN, Rabbany SY, Rafii S. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature 2010;468:310-315.
[115] DeLeve LD. Liver sinusoidal endothelial cells and liver regeneration. J Clin Invest 2013;123:1861-1866.
[116] Lindroos PM, Zarnegar R, Michalopoulos GK. Hepatocyte growth factor (hepatopoietin a) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology 1991;13:743-750.
[117] Currier AR, Sabla G, Locaputo S, Melin-Aldana H, Degen JL, Bezerra JA. Plasminogen directs the pleiotropic effects of upa in liver injury and repair. Am J Physiol Gastrointest Liver Physiol 2003;284:G508-515.
[118] Shimizu M, Hara A, Okuno M, Matsuno H, Okada K, Ueshima S, Matsuo O, Niwa M, Akita K, Yamada Y, Yoshimi N, Uematsu T, Kojima S, Friedman SL, Moriwaki H, Mori H. Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: Impaired activation of hepatocyte growth factor after fas-mediated massive hepatic apoptosis. Hepatology 2001;33:569-576.
[119] Pediaditakis P, Lopez-Talavera JC, Petersen B, Monga SP, Michalopoulos GK. The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat. Hepatology 2001;34:688-693.
[120] Mars WM, Zarnegar R, Michalopoulos GK. Activation of hepatocyte growth factor by the plasminogen activators upa and tpa. Am J Pathol 1993;143:949-958.
[121] Maroun CR, Rowlands T. The met receptor tyrosine kinase: A key player in oncogenesis and drug resistance. Pharmacol Ther 2014;142:316-338.
[122] Nakamura T, Mizuno S. The discovery of hepatocyte growth factor (hgf) and its significance for cell biology, life sciences and clinical medicine. Proc Jpn Acad Ser B Phys Biol Sci 2010;86:588-610.
[123] Borowiak M, Garratt AN, Wustefeld T, Strehle M, Trautwein C, Birchmeier C. Met provides essential signals for liver regeneration. Proc Natl Acad Sci U S A 2004;101:10608- 10613.
[124] Okano J, Shiota G, Matsumoto K, Yasui S, Kurimasa A, Hisatome I, Steinberg P, Murawaki Y. Hepatocyte growth factor exerts a proliferative effect on oval cells through the pi3k/akt signaling pathway. Biochem Biophys Res Commun 2003;309:298-304.
[125] Ozaki M, Haga S, Zhang HQ, Irani K, Suzuki S. Inhibition of hypoxia/reoxygenation-induced oxidative stress in hgf- stimulated antiapoptotic signaling: Role of pi3-k and akt kinase upon rac1. Cell Death Differ 2003;10:508-515.
[126] Xiao GH, Jeffers M, Bellacosa A, Mitsuuchi Y, Vande Woude GF, Testa JR. Anti-apoptotic signaling by hepatocyte growth factor/met via the phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways. Proc Natl Acad Sci U S A 2001;98:247-252.
[127] Gao C, Jokerst R, Gondipalli P, Cai SR, Kennedy S, Flye MW, Ponder KP. Lipopolysaccharide potentiates the effect of hepatocyte growth factor on hepatocyte replication in rats by augmenting ap-1 activity. Hepatology 1999;30:1405-1416.
[128] PuriN, Salgia R. Synergism of egfr and c-met pathways, cross- talk and inhibition, in non-small cell lung cancer. J Carcinog 2008;7:9.
[129] Jo M, Stolz DB, Esplen JE, Dorko K, Michalopoulos GK, Strom SC. Cross-talk between epidermal growth factor receptor and c-met signal pathways in transformed cells. J Biol Chem 2000;275:8806-8811.
[130] Skov Olsen P, Boesby S, Kirkegaard P, Therkelsen K, Almdal T, Poulsen SS, Nexo E. Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Hepatology 1988;8:992-996.
[131] Cruise JL, Knechtle SJ, Bollinger RR, Kuhn C, Michalopoulos G. Alpha 1-adrenergic effects and liver regeneration. Hepatology 1987;7:1189-1194.
[132] Olsen PS, Poulsen SS, Kirkegaard P. Adrenergic effects on secretion of epidermal growth factor from brunner's glands. Gut 1985;26:920-927.
[133] Knopp J, Jezova D, Rusnak M, Jaroscakova I, Farkas R, Kvetnansky R. Changes in plasma catecholamine and corticosterone levels and gene expression of key enzymes of catecholamine biosynthesis in partially hepatectomized rats. Endocr Regul 1999;33:145-153.
[134] Mead JE, Fausto N. Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci U S A 1989;86:1558-1562.
[135] Webber EM, Wu JC, Wang L, Merlino G, Fausto N. Overexpression of transforming growth factor-alpha causes liver enlargement and increased hepatocyte proliferation in transgenic mice. Am J Pathol 1994;145:398-408.
[136] Russell WE, Kaufmann WK, Sitaric S, Luetteke NC, Lee DC. Liver regeneration and hepatocarcinogenesis in transforming growth factor-alpha-targeted mice. Mol Carcinog 1996;15:183- 189.
[137] Nakano T, Raines EW, Abraham JA, Klagsbrun M, Ross R. Lysophosphatidylcholine upregulates the level of heparin- binding epidermal growth factor-like growth factor mrna in human monocytes. Proc Natl Acad Sci U S A 1994;91:1069- 1073.
[138] Edwards JP, Zhang X, Mosser DM. The expression of heparin- binding epidermal growth factor-like growth factor by regulatory macrophages. J Immunol 2009;182:1929-1939.
[139] Higashiyama S. Metalloproteinase-mediated shedding of heparin-binding egf-like growth factor and its pathophysiological roles. Protein Pept Lett 2004;11:443-450.
[140] Ito N, Kawata S, Tamura S, Kiso S, Tsushima H, Damm D, Abraham JA, Higashiyama S, Taniguchi N, Matsuzawa Y. Heparin-binding egf-like growth factor is a potent mitogen for rat hepatocytes. Biochem Biophys Res Commun 1994;198:25- 31.
[141] Kiso S, Kawata S, Tamura S, Higashiyama S, Ito N, Tsushima H, Taniguchi N, Matsuzawa Y. Role of heparin-binding epidermal growth factor-like growth factor as a hepatotrophic factor in rat liver regeneration after partial hepatectomy. Hepatology 1995;22:1584-1590.
[142] Yamada A, Kawata S, Tamura S, Kiso S, Higashiyama S, Umeshita K, Sakon M, Taniguchi N, Monden M, Matsuzawa Y. Plasma heparin-binding egf-like growth factor levels in patients after partial hepatectomy as determined with an enzyme-linked immunosorbent assay. Biochem Biophys Res Commun 1998;246:783-787.
[143] Sakuda S, Tamura S, Yamada A, Miyagawa J, Yamamoto K, Kiso S, Ito N, Higashiyama S, Taniguchi N, Kawata S, Matsuzawa Y. Nf-kappab activation in non-parenchymal liver cells after partial hepatectomy in rats: Possible involvement in expression of heparin-binding epidermal growth factor-like growth factor. J Hepatol 2002;36:527-533.
[144] Berasain C, Garcia-Trevijano ER, Castillo J, ErrobaE, Lee DC, Prieto J, Avila MA. Amphiregulin: An early trigger of liver regeneration in mice. Gastroenterology 2005;128:424-432.
[145] Hou Z, Yanaga K, Kamohara Y, Eguchi S, Tsutsumi R, Furui J, Kanematsu T. A new suppressive agent against interleukin- 1beta and tumor necrosis factor-alpha enhances liver regeneration after partial hepatectomy in rats. Hepatol Res 2003;26:40-46.
[146] Tsutsumi R, Kamohara Y, Eguchi S, Azuma T, Fujioka H, Okudaira S, Yanaga K, Kanematsu T. Selective suppression of initial cytokine response facilitates liver regeneration after extensive hepatectomy in rats. Hepatogastroenterology 2004;51:701-704.
[147] Ogiso T, Nagaki M, Takai S, Tsukada Y, Mukai T, Kimura K, Moriwaki H. Granulocyte colony-stimulating factor impairs liver regeneration in mice through the up-regulation of interleukin-1beta. J Hepatol 2007;47:816-825.
[148] Tsujii H, Okamoto Y, Kikuchi E, Matsumoto M, Nakano H. Prostaglandin e2 and rat liver regeneration. Gastroenterology 1993;105:495-499.
[149] Goss JA, Mangino MJ, Flye MW. Kupffer cell autoregulation of il-1 production by pge2 during hepatic regeneration. J Surg Res 1992;52:422-428.
[150] Goss JA, Mangino MJ, Flye MW. Prostaglandin e2 production during hepatic regeneration downregulates kupffer cell il-6 production. Ann Surg 1992;215:553-559; discussion 559-560.
[151] Zhao Y, Meng C, Wang Y, Huang H, Liu W, Zhang JF, Zhao H, Feng B, Leung PS, Xia Y. Interleukin (il)-1beta inhibits beta-klotho expression and fgf19 signaling in hepatocytes. Am J Physiol Endocrinol Metab 2016;310:E289-300.
[152] Ledda-Columbano GM, Curto M, Piga R, Zedda AI, Menegazzi M, Sartori C, Shinozuka H, Bluethmann H, Poli V, Ciliberto G, Columbano A. In vivo hepatocyte proliferation is inducible through a tnf and il-6-independent pathway. Oncogene 1998;17:1039-1044.
[153] Cruise JL, Houck KA, Michalopoulos GK. Induction of DNA synthesis in cultured rat hepatocytes through stimulation of alpha 1 adrenoreceptor by norepinephrine. Science 1985;227:749-751.
[154] Yamada Y, Webber EM, Kirillova I, Peschon JJ, Fausto N. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: Requirement for type 1 but not type 2 receptor. Hepatology 1998;28:959-970.
[155] Kan M, Huang JS, Mansson PE, Yasumitsu H, Carr B, McKeehan WL. Heparin-binding growth factor type 1 (acidic fibroblast growth factor): A potential biphasic autocrine and paracrine regulator of hepatocyte regeneration. Proc Natl Acad Sci U S A 1989;86:7432-7436.
[156] Steiling H, Wustefeld T, Bugnon P, Brauchle M, Fassler R, Teupser D, Thiery J, Gordon JI, Trautwein C, Werner S. Fibroblast growth factor receptor signalling is crucial for liver homeostasis and regeneration. Oncogene 2003;22:4380-4388.
[157] Campbell JS, Hughes SD, Gilbertson DG, Palmer TE, Holdren MS, Haran AC, Odell MM, Bauer RL, Ren HP, Haugen HS, Yeh MM, Fausto N. Platelet-derived growth factor c induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci U S A 2005;102:3389-3394.
[158] Ren X, Carpenter A, Hogaboam C, Colletti L. Mitogenic properties of endogenous and pharmacological doses of macrophage inflammatory protein-2 after 70% hepatectomy in the mouse. Am J Pathol 2003;163:563-570.
[159] Yamauchi H, Uetsuka K, Okada T, Nakayama H, Doi K. Impaired liver regeneration after partial hepatectomy in db/db mice. Exp Toxicol Pathol 2003;54:281-286.
[160] Starzl TE, Porter KA, Putnam CW. Insulin, glucagon, and the control of hepatic structure, function, and capacity for regeneration. Metabolism 1976;25:1429-1434.
[161] Furukawa K, Terayama H. Pattern of glycosaminoglycans and glycoproteins associated with nuclei of regenerating liver of rat. Biochim Biophys Acta 1979;585:575-588.
[162] Vrochides D, Papanikolaou V, Pertoft H, Antoniades AA, Heldin P. Biosynthesis and degradation of hyaluronan by nonparenchymal liver cells during liver regeneration. Hepatology 1996;23:1650-1655.
[163] Della Fazia MA, Pettirossi V, Ayroldi E, Riccardi C, Magni MV, Servillo G. Differential expression of cd44 isoforms during liver regeneration in rats. J Hepatol 2001;34:555-561.
[164] Ogata T, Okuda K, Ueno T, Saito N, Aoyagi S. Serum hyaluronan as a predictor of hepatic regeneration after hepatectomy in humans. Eur J Clin Invest 1999;29:780-785.
[165] Ghahary A, Minuk GY, Luo J, Gauthier T, Murphy LJ. Effects of partial hepatectomy on hepatic insulinlike growth factor binding protein-1 expression. Hepatology 1992;15:1125-1131.
[166] Weir E, Chen Q, DeFrances MC, Bell A, Taub R, Zarnegar R. Rapid induction of mrnas for liver regeneration factor and insulin-like growth factor binding protein-1 in primary cultures of rat hepatocytes by hepatocyte growth factor and epidermal growth factor. Hepatology 1994;20:955-960.
[167] Leu JI, Crissey MA, Leu JP, Ciliberto G, Taub R. Interleukin- 6-induced stat3 and ap-1 amplify hepatocyte nuclear factor 1- mediated transactivation of hepatic genes, an adaptive response to liver injury. Mol Cell Biol 2001;21:414-424.
[168] Liu Y, Shao M, Wu Y, Yan C, Jiang S, Liu J, Dai J, Yang L, Li J, Jia W, Rui L, Liu Y. Role for the endoplasmic reticulum stress sensor ire1alpha in liver regenerative responses. J Hepatol 2015;62:590-598.
[169] Lee AH, Iwakoshi NN, Anderson KC, Glimcher LH. Proteasome inhibitors disrupt the unfolded protein response in myeloma cells. Proc Natl Acad Sci U S A 2003;100:9946- 9951.
[170] Gu F, Nguyen DT, Stuible M, Dube N, Tremblay ML, Chevet E. Protein-tyrosine phosphatase 1b potentiates ire1 signaling during endoplasmic reticulum stress. J Biol Chem 2004;279:49689-49693.
[171] Xue X, Piao JH, Nakajima A, Sakon-Komazawa S, Kojima Y, Mori K, Yagita H, Okumura K, Harding H, Nakano H. Tumor necrosis factor alpha (tnfalpha) induces the unfolded protein response (upr) in a reactive oxygen species (ros)-dependent fashion, and the upr counteracts ros accumulation by tnfalpha. J Biol Chem 2005;280:33917-33925.
[172] Casado M, Callejas NA, Rodrigo J, Zhao X, Dey SK, Bosca L, Martin-Sanz P. Contribution of cyclooxygenase 2 to liver regeneration after partial hepatectomy. FASEB J 2001;15:2016-2018.
[173] Heger M, van Golen RF, Broekgaarden M, Michel MC. The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer. Pharmacol Rev 2014;66:222-307.
[174] Dieter P, Hempel U, Kamionka S, Kolada A, Malessa B, Fitzke E, Tran-Thi TA. Prostaglandin e2 affects differently the release of inflammatory mediators from resident macrophages by lps and muramyl tripeptides. Mediators Inflamm 1999;8:295-303.
[175] Yang Y, Zhao Z, Liu Y, Kang X, Zhang H, Meng M. Suppression of oxidative stress and improvement of liver functions in mice by ursolic acid via lkb1-amp-activated protein kinase signaling. J Gastroenterol Hepatol 2015;30:609- 618.
[176] Hernanz R, Briones AM, Salaices M, Alonso MJ. New roles for old pathways? A circuitous relationship between reactive oxygen species and cyclo-oxygenase in hypertension. Clin Sci (Lond) 2014;126:111-121.
[177] Korbecki J, Baranowska-Bosiacka I, Gutowska I, Chlubek D. The effect of reactive oxygen species on the synthesis of prostanoids from arachidonic acid. J Physiol Pharmacol 2013;64:409-421.
[178] Rescan C, Coutant A, Talarmin H, Theret N, Glaise D, Guguen-Guillouzo C, Baffet G. Mechanism in the sequential control of cell morphology and s phase entry by epidermal growth factor involves distinct mek/erk activations. Mol Biol Cell 2001;12:725-738.
[179] Coutant A, Rescan C, Gilot D, Loyer P, Guguen-Guillouzo C, Baffet G. Pi3k-frap/mtor pathway is critical for hepatocyte proliferation whereas mek/erk supports both proliferation and survival. Hepatology 2002;36:1079-1088.
[180] Flodby P, Antonson P, Barlow C, Blanck A, Porsch-Hallstrom I, Xanthopoulos KG. Differential patterns of expression of three c/ebp isoforms, hnf-1, and hnf-4 after partial hepatectomy in rats. Exp Cell Res 1993;208:248-256.
[181] Ramji DP, Foka P. Ccaat/enhancer-binding proteins: Structure, function and regulation. Biochem J 2002;365:561-575.
[182] Diehl AM. Roles of ccaat/enhancer-binding proteins in regulation of liver regenerative growth. J Biol Chem 1998;273:30843-30846.
[183] Hendricks-Taylor LR, Darlington GJ. Inhibition of cell proliferation by c/ebp alpha occurs in many cell types, does not require the presence of p53 or rb, and is not affected by large t- antigen. Nucleic Acids Res 1995;23:4726-4733.
[184] Diehl AM, Johns DC, Yang S, Lin H, Yin M, Matelis LA, Lawrence JH. Adenovirus-mediated transfer of ccaat/enhancer- binding protein-alpha identifies a dominant antiproliferative role for this isoform in hepatocytes. J Biol Chem 1996;271:7343-7350.
[185] Greenbaum LE, Li W, Cressman DE, Peng Y, Ciliberto G, Poli V, Taub R. Ccaat enhancer- binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy. J Clin Invest 1998;102:996-1007.
[186] Yu X, Si J, Zhang Y, Dewille JW. Ccaat/enhancer binding protein-delta (c/ebp-delta) regulates cell growth, migration and differentiation. Cancer Cell Int 2010;10:48.
[187] Hung JH, Su IJ, Lei HY, Wang HC, Lin WC, Chang WT, Huang W, Chang WC, Chang YS, Chen CC, Lai MD. Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of nf-kappab and pp38 mitogen-activated protein kinase. J Biol Chem 2004;279:46384-46392.
[188] Han J, Lee JD, Bibbs L, Ulevitch RJ. A map kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994;265:808-811.
[189] Lee JC, Young PR. Role of csb/p38/rk stress response kinase in lps and cytokine signaling mechanisms. J Leukoc Biol 1996;59:152-157.
[190] Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995;270:7420-7426.
[191] Moriguchi T, Toyoshima F, Gotoh Y, Iwamatsu A, Irie K, Mori E, KuroyanagiN, Hagiwara M, Matsumoto K, Nishida E. Purification and identification of a major activator for p38 from osmotically shocked cells. Activation of mitogen-activated protein kinase kinase 6 by osmotic shock, tumor necrosis factor-alpha, and h2o2. J Biol Chem 1996;271:26981-26988.
[192] Guyton KZ, Liu Y, Gorospe M, Xu Q, Holbrook NJ. Activation of mitogen-activated protein kinase by h2o2. Role in cell survival following oxidant injury. J Biol Chem 1996;271:4138-4142.
[193] Lander HM, Jacovina AT, Davis RJ, Tauras JM. Differential activation of mitogen-activated protein kinases by nitric oxide- related species. J Biol Chem 1996;271:19705-19709.
[194] Li H, Lin X. Positive and negative signaling components involved in tnfalpha-induced nf-kappab activation. Cytokine 2008;41:1-8.
[195] Janssen-Heininger YM, Poynter ME, Baeuerle PA. Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappab. Free Radic Biol Med 2000;28:1317-1327.
[196] Chen X, Zhao Y, Wang F, BeiY, Xiao J, Yang C. Micrornas in liver regeneration. Cell Physiol Biochem 2015;37:615-628.
[197] Kren BT, Wong PY, Shiota A, Zhang X, Zeng Y, Steer CJ. Polysome trafficking of transcripts and micrornas in regenerating liver after partial hepatectomy. Am J Physiol Gastrointest Liver Physiol 2009;297:G1181-1192.
[198] Raschzok N, Werner W, Sallmon H, Billecke N, Dame C, Neuhaus P, Sauer IM. Temporal expression profiles indicate a primary function for microrna during the peak of DNA replication after rat partial hepatectomy. Am J Physiol Regul Integr Comp Physiol 2011;300:R1363-1372.
[199] Chaveles I, Zaravinos A, Habeos IG, Karavias DD, Maroulis I, Spandidos DA, Karavias D. Microrna profiling in murine liver after partial hepatectomy. Int J Mol Med 2012;29:747-755.
[200] Chen X, Murad M, Cui YY, Yao LJ, Venugopal SK, Dawson K, Wu J. Mirna regulation of liver growth after 50% partial hepatectomy and small size grafts in rats. Transplantation 2011;91:293-299.
[201] Yuan B, Dong R, Shi D, Zhou Y, Zhao Y, Miao M, Jiao B. Down-regulation of mir-23b may contribute to activation of the tgf-beta1/smad3 signalling pathway during the termination stage of liver regeneration. FEBS Lett 2011;585:927-934.
[202] Lee YS, Nakahara K, Pham JW, Kim K, He Z, Sontheimer EJ, Carthew RW. Distinct roles for drosophila dicer-1 and dicer-2 in the sirna/mirna silencing pathways. Cell 2004;117:69-81.
[203] Hand NJ, Master ZR, Le Lay J, Friedman JR. Hepatic function is preserved in the absence of mature micrornas. Hepatology 2009;49:618-626.
[204] Zhou J, Ju W, Wang D, Wu L, Zhu X, Guo Z, He X. Down- regulation of microrna-26a promotes mouse hepatocyte proliferation during liver regeneration. PLoS One 2012;7:e33577.
[205] Pan C, Chen H, Wang L, Yang S, Fu H, Zheng Y, Miao M, Jiao B. Down-regulation of mir-127 facilitates hepatocyte proliferation during rat liver regeneration. PLoS One 2012;7:e39151.
[206] Zhang B, Pan X, Cobb GP, Anderson TA. Micrornas as oncogenes and tumor suppressors. Dev Biol 2007;302:1-12.
[207] Ng R, Song G, Roll GR, Frandsen NM, Willenbring H. A microrna-21 surge facilitates rapid cyclin d1 translation and cell cycle progression in mouse liver regeneration. J Clin Invest 2012;122:1097-1108.
[208] Chen H, Sun Y, Dong R, Yang S, Pan C, Xiang D, Miao M, Jiao B. Mir-34a is upregulated during liver regeneration in rats and is associated with the suppression of hepatocyte proliferation. PLoS One 2011;6:e20238.
[209] Cirera-Salinas D, Pauta M, Allen RM, Salerno AG, Ramirez CM, Chamorro-Jorganes A, Wanschel AC, Lasuncion MA, Morales-Ruiz M, Suarez Y, Baldan A, Esplugues E, Fernandez-Hernando C. Mir-33 regulates cell proliferation and cell cycle progression. Cell Cycle 2012;11:922-933.
[210] Song G, Sharma AD, Roll GR, Ng R, Lee AY, Blelloch RH, Frandsen NM, Willenbring H. Micrornas control hepatocyte proliferation during liver regeneration. Hepatology 2010;51:1735-1743.
[211] Marquez RT, Wendlandt E, Galle CS, Keck K, McCaffrey AP. Microrna-21 is upregulated during the proliferative phase of liver regeneration, targets pellino-1, and inhibits nf-kappab signaling. Am J Physiol Gastrointest Liver Physiol 2010;298:G535-541.
[212] Castro RE, Ferreira DM, Zhang X, Borralho PM, Sarver AL, Zeng Y, Steer CJ, Kren BT, Rodrigues CM. Identification of micrornas during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid. Am J Physiol Gastrointest Liver Physiol 2010;299:G887-897.
[213] Yan-nan B, Zhao-yan Y, Li-xi L, jiang Y, Qing-jie X, Yong Z. Microrna-21 accelerates hepatocyte proliferation in vitro via pi3k/akt signaling by targeting pten. Biochem Biophys Res Commun 2014;443:802-807.
[214] Yuan Q, Loya K, Rani B, Mobus S, Balakrishnan A, Lamle J, Cathomen T, Vogel A, Manns MP, Ott M, Cantz T, Sharma AD. Microrna-221 overexpression accelerates hepatocyte proliferation during liver regeneration. Hepatology 2013;57:299-310.
[215] Bei Y, Song Y, Wang F, Dimitrova-Shumkovska J, Xiang Y, Zhao Y, Liu J, Xiao J, Yang C. Mir-382 targeting pten-akt axis promotes liver regeneration. Oncotarget 2016;7:1584-1597.
[216] Raschzok N, Sallmon H, Dame C, Sauer IM. Liver regeneration after partial hepatectomy: Inconsistent results of expression screenings for human, mouse, and rat micrornas. Am J Physiol Gastrointest Liver Physiol 2012;302:G470-471.
[217] Shu J, Kren BT, Xia Z, Wong PY, Li L, Hanse EA, Min MX, Li B, Albrecht JH, Zeng Y, Subramanian S, Steer CJ. Genomewide microrna down-regulation as a negative feedback mechanism in the early phases of liver regeneration. Hepatology 2011;54:609-619.
[218] Schug J, McKenna LB, Walton G, Hand N, Mukherjee S, Essuman K, Shi Z, Gao Y, Markley K, Nakagawa M, Kameswaran V, Vourekas A, Friedman JR, Kaestner KH, Greenbaum LE. Dynamic recruitment of micrornas to their mrna targets in the regenerating liver. BMC Genomics 2013;14:264.
[219] Benes V, Collier P, Kordes C, Stolte J, Rausch T, Muckentaler MU, Haussinger D, Castoldi M. Identification of cytokine- induced modulation of microrna expression and secretion as measured by a novel microrna specific qpcr assay. Sci Rep 2015;5:11590.
[220] Barone M, Francavilla A, Polimeno L, Ierardi E, Romanelli D, Berloco P, Di Leo A, Panella C. Modulation of rat hepatocyte proliferation by bile salts: In vitro and in vivo studies. Hepatology 1996;23:1159-1166.
[221] Ueda J, Chijiiwa K, Nakano K, Zhao G, Tanaka M. Lack of intestinal bile results in delayed liver regeneration of normal rat liver after hepatectomy accompanied by impaired cyclin e- associated kinase activity. Surgery 2002;131:564-573.
[222] Otao R, Beppu T, Isiko T, Mima K, Okabe H, Hayashi H, Masuda T, Chikamoto A, Takamori H, Baba H. External biliary drainage and liver regeneration after major hepatectomy. Br J Surg 2012;99:1569-1574.
[223] Rodrigues AD, Lai Y, Cvijic ME, Elkin LL, Zvyaga T, Soars MG. Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: Mechanistic considerations beyond the direct inhibition of the bile salt export pump. Drug MetabDispos 2014;42:566-574.
[224] Li T, Chiang JY. Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev 2014;66:948-983.
[225] Chiang JY. Bile acids: Regulation of synthesis. J Lipid Res 2009;50:1955-1966.
[226] Myant NB, Mitropoulos KA. Cholesterol 7 alpha-hydroxylase. J Lipid Res 1977;18:135-153.
[227] Bjorkhem I, Einarsson K, Melone P, Hylemon P. Mechanism of intestinal formation of deoxycholic acid from cholic acid in humans: Evidence for a 3-oxo-delta 4-steroid intermediate. J Lipid Res 1989;30:1033-1039.
[228] Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res 2006;47:241-259.
[229] Hylemon PB, Melone PD, Franklund CV, Lund E, Bjorkhem I. Mechanism of intestinal 7 alpha-dehydroxylation of cholic acid: Evidence that allo-deoxycholic acid is an inducible side- product. J Lipid Res 1991;32:89-96.
[230] Visschers RG, Luyer MD, Schaap FG, Olde Damink SW, Soeters PB. The gut-liver axis. Curr Opin Clin Nutr Metab Care 2013;16:576-581.
[231] Alnouti Y. Bile acid sulfation: A pathway of bile acid elimination and detoxification. Toxicol Sci 2009;108:225-246.
[232] Chiang JYL. Bile acid metabolism and signaling. Compr Physiol 2013;3:1191-1212.
[233] Hofmann AF. The enterohepatic circulation of bile acids in mammals: Form and functions. Front Biosci (Landmark Ed) 2009;14:2584-2598.
[234] Woolbright BL, Jaeschke H. Critical factors in the assessment of cholestatic liver injury in vitro. Methods Mol Biol 2015;1250:363-376.
[235] Zhang Y, Hong JY, Rockwell CE, Copple BL, Jaeschke H, Klaassen CD. Effect of bile duct ligation on bile acid composition in mouse serum and liver. Liver Int 2012;32:58- 69.
[236] Otsuki M. Pathophysiological role of cholecystokinin in humans. J Gastroenterol Hepatol 2000;15 Suppl:D71-83.
[237] Hagenbuch B, Stieger B, Foguet M, Lubbert H, Meier PJ. Functional expression cloning and characterization of the hepatocyte na+/bile acid cotransport system. Proc Natl Acad Sci U S A 1991;88:10629-10633.
[238] Stieger B, Hagenbuch B, Landmann L, Hochli M, Schroeder A, Meier PJ. In situ localization of the hepatocytic na+/taurocholate cotransporting polypeptide in rat liver. Gastroenterology 1994;107:1781-1787.
[239] Meier PJ, Stieger B. Bile salt transporters. Annu Rev Physiol 2002;64:635-661.
[240] Vaz FM, Paulusma CC, Huidekoper H, de Ru M, Lim C, Koster J, Ho-Mok K, Bootsma AH, Groen AK, Schaap FG, Oude Elferink RP, Waterham HR, Wanders RJ. Sodium taurocholate cotransporting polypeptide (slc10a1) deficiency: Conjugated hypercholanemia without a clear clinical phenotype. Hepatology 2015;61:260-267.
[241] Slijepcevic D, Kaufman C, Wichers CG, Gilglioni EH, Lempp FA, Duijst S, de Waart DR, Elferink RP, Mier W, Stieger B, Beuers U, Urban S, van de Graaf SF. Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+) -taurocholate cotransporting polypeptide knockout mice. Hepatology 2015;62:207-219.
[242] Boyer JL. Bile formation and secretion. Compr Physiol 2013;3:1035-1078.
[243] Akita H, Suzuki H, Ito K, Kinoshita S, Sato N, Takikawa H, Sugiyama Y. Characterization of bile acid transport mediated by multidrug resistance associated protein 2 and bile salt export pump. Biochim Biophys Acta 2001;1511:7-16.
[244] Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, Kwiterovich P, Shan B, Barnes R, Hobbs HH. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent abc transporters. Science 2000;290:1771-1775.
[245] Smit JJ, Schinkel AH, Oude Elferink RP, Groen AK, Wagenaar E, van Deemter L, Mol CA, Ottenhoff R, van der Lugt NM, van Roon MA, et al. Homozygous disruption of the murine mdr2 p-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993;75:451- 462.
[246] Shneider BL. Expression cloning of the ileal sodium-dependent bile acid transporter. J Pediatr Gastroenterol Nutr 1995;20:233- 235.
[247] Ballatori N, Christian WV, Lee JY, Dawson PA, Soroka CJ, Boyer JL, Madejczyk MS, Li N. Ostalpha-ostbeta: A major baso